Nucleic acid molecules and uses thereof

TW202635885APending Publication Date: 2026-09-01GRITELEMENT THERAPEUTICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114152001
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-31
Filing Date
2025-12-30
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001075079_001
    Figure TWG2TA001075079_001
  • Figure TWG2TA001075079_002
    Figure TWG2TA001075079_002
  • Figure TWG2TA001075079_003
    Figure TWG2TA001075079_003
Patent Text Reader

Abstract

This disclosure relates to a nucleic acid molecule comprising (a) a sequence encoding phenylalanine hydroxylase (PAH), and / or (b) a small nucleic acid that reduces or inhibits the expression of endogenous PAH. The disclosure also relates to a vector, a cell, and a pharmaceutical composition comprising the nucleic acid molecule, as well as methods for using them to treat a disease or disorder associated with insufficient phenylalanine hydroxylase activity.
Need to check novelty before this filing date? Find Prior Art